232 related articles for article (PubMed ID: 12196460)
1. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.
Meyer MM; Levin K; Grimmsmann T; Perwitz N; Eirich A; Beck-Nielsen H; Klein HH
Diabetes; 2002 Sep; 51(9):2691-7. PubMed ID: 12196460
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects.
Kim YB; Ciaraldi TP; Kong A; Kim D; Chu N; Mohideen P; Mudaliar S; Henry RR; Kahn BB
Diabetes; 2002 Feb; 51(2):443-8. PubMed ID: 11812753
[TBL] [Abstract][Full Text] [Related]
3. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.
Kruszynska YT; Worrall DS; Ofrecio J; Frias JP; Macaraeg G; Olefsky JM
J Clin Endocrinol Metab; 2002 Jan; 87(1):226-34. PubMed ID: 11788651
[TBL] [Abstract][Full Text] [Related]
6. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats.
Kanoh Y; Bandyopadhyay G; Sajan MP; Standaert ML; Farese RV
Endocrinology; 2001 Apr; 142(4):1595-605. PubMed ID: 11250941
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
[TBL] [Abstract][Full Text] [Related]
9. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise.
Thong FS; Derave W; Kiens B; Graham TE; Ursø B; Wojtaszewski JF; Hansen BF; Richter EA
Diabetes; 2002 Mar; 51(3):583-90. PubMed ID: 11872654
[TBL] [Abstract][Full Text] [Related]
10. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].
Storgaard H; Song XM; Jensen CB; Madsbad S; Björnholm M; Vaag A; Zierath JR
Diabetes; 2001 Dec; 50(12):2770-8. PubMed ID: 11723060
[TBL] [Abstract][Full Text] [Related]
11. Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes.
Levin K; Hother-Nielsen O; Henriksen JE; Beck-Nielsen H
Diabetes Care; 2004 Jan; 27(1):148-54. PubMed ID: 14693981
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
Barthel A; Krüger KD; Roth RA; Joost HG
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):290-5. PubMed ID: 11919653
[TBL] [Abstract][Full Text] [Related]
13. Delays in insulin signaling towards glucose disposal in human skeletal muscle.
Grimmsmann T; Levin K; Meyer MM; Beck-Nielsen H; Klein HH
J Endocrinol; 2002 Mar; 172(3):645-51. PubMed ID: 11874713
[TBL] [Abstract][Full Text] [Related]
14. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
Miyazaki Y; He H; Mandarino LJ; DeFronzo RA
Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study.
Karlsson HK; Hällsten K; Björnholm M; Tsuchida H; Chibalin AV; Virtanen KA; Heinonen OJ; Lönnqvist F; Nuutila P; Zierath JR
Diabetes; 2005 May; 54(5):1459-67. PubMed ID: 15855334
[TBL] [Abstract][Full Text] [Related]
17. Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle.
Temofonte N; Sajan MP; Nimal S; Pastoor T; Fumero C; Casaubon L; Powe JL; Standaert ML; Farese RV
Diabetologia; 2009 Jan; 52(1):60-4. PubMed ID: 18972094
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
Hevener AL; Reichart D; Janez A; Olefsky J
Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
